Tirzepatide recalls
The FDA has published 9 recalls involving Tirzepatide since 2023. The latest was reported on 5 Nov 2025. Most were for sterility. ProRx has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls9since 2023
Last 12 months1reported
Class I111% of total
Ongoing9latest 5 Nov 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 11%Class II 8 89%Class III 0 0%
Why tirzepatide is recalled
Companies
By year
Ongoing tirzepatide recalls
9 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide Injection, 27 mg/ (9 mg/mL) Multidose Vial recalled by ProRx | ProRx | Sterility | TX, UT |
| Drug | CLASS II | Tirzepatide, 60mg/ for Injection vial lyophilized recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL recalled | Thrive Health and Wellness, LLC | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL recalled | Thrive Health and Wellness, LLC | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide 20 mg/ (10/mg/mL) recalled by ProRx | ProRx | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide 60 mg/ (20/mg/mL) recalled by ProRx | ProRx | Sterility | Nationwide |
All tirzepatide recalls, newest first
9 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tirzepatide Injection, 27 mg/ (9 mg/mL) Multidose Vial recalled by ProRx | ProRx | Sterility | TX, UT |
| Drug | CLASS II | Tirzepatide, 60mg/ for Injection vial lyophilized recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL recalled | Thrive Health and Wellness, LLC | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL recalled | Thrive Health and Wellness, LLC | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide 20 mg/ (10/mg/mL) recalled by ProRx | ProRx | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide 60 mg/ (20/mg/mL) recalled by ProRx | ProRx | Sterility | Nationwide |
| Drug | CLASS II | Tirzepatide (10 mg/mL) and 20 mg/mL Multidose SC Injection recalled | ProRx | Sterility | Nationwide |
| Drug | CLASS I | Tirzepatide 10 mg/ Sterile Solution Multi-dose vial recalled | Revive Rx | Packaging Defects | Nationwide |
| Drug | CLASS II | Tirzepatide 10 mg/ Sterile Solution- Vial recalled by Revive Rx | Revive Rx | Other | Nationwide |
Should you stop taking Tirzepatide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.